Please assess the completion status of the following clinical trial:

Trial Title: Buprenorphine in the Emergency Department

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Presenting to the ED in opioid withdrawal or soon to be in withdrawal~2. Minimum age 16~3. English speaking~4. Active phone number~5. Ontario Health Insurance Program card~Exclusion Criteria:~1. Pregnant~2. Currently enrolled in a methadone or buprenorphine maintenance~3. Benzodiazepine addiction (or taking \>50mg of valium equivalent/day)~4. Acute hepatitis or liver failure

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Buprenorphine (Type: EXPERIMENTAL): Patient receives buprenorphine in the emergency room based on a clinical trial protocol as well as a take home prescription for buprenorphine
- Clonidine (Type: ACTIVE_COMPARATOR): Patient receives clonidine in the emergency room based on a clinical trial protocol and also receives a take home prescription for clonidine

Based on this trial design, predict the completion outcome and termination type (if applicable).